Skip to main content
Top
Published in: Supportive Care in Cancer 4/1999

01-06-1999 | ORIGINAL ARTICLE

Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel

Authors: Jacob Gilad, Klaris Riesenberg, Wilmosh Mermershtain, Abraham Borer, Avi Porath, F. Schlaeffer

Published in: Supportive Care in Cancer | Issue 4/1999

Login to get access
Metadata
Title
Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
Authors
Jacob Gilad
Klaris Riesenberg
Wilmosh Mermershtain
Abraham Borer
Avi Porath
F. Schlaeffer
Publication date
01-06-1999
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/1999
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050258

Other articles of this Issue 4/1999

Supportive Care in Cancer 4/1999 Go to the issue

OriginalPaper

MEETING HIGHLIGHT

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine